DUBLIN, Jan. 10, 2024 /PRNewswire/ — The “Digital Transformation and Emerging Technologies in the Healthcare Industry – Thematic Intelligence” report has been added to ResearchAndMarkets.com’s offering.
This report tracks the progress of digital transformation in the healthcare industry, examines the business preparedness to embrace innovations, and uncovers the current and future technology-related investment trends.
Digital transformation is steadily making progress in the pharmaceutical industry, with a focus on enabling operations and driving innovation within the healthcare sector. The majority of survey respondents in the industry express optimism about the growth of digital transformation within their organizations. However, several challenges hinder the adoption of emerging technologies, including the lack of specific skills and talents, insufficient funding, and organizational silos.
Concerns related to digital privacy, data security, and increased cyber risks are at the forefront of worries associated with digital transformation. To ensure successful digital transformation, building a culture of constant change and strong leadership are considered essential drivers.
Pharmaceutical executives are prioritizing investments in big data, digital media, and cloud computing in the present, while looking to invest in AI, big data, and digital media in the near future. AI and big data are expected to remain the most disruptive forces in the healthcare sector for the next two years, driving further advancements in the industry.
Key Highlights
Inflation can act as both obstacle and enabler for digital transformation
Lack of skills and talents is the top factor hindering digital transformation efforts
Digital privacy and data security and increased cyber risks are the main concerns associated with digitalization
Strong leadership and cultivating a culture of change are the key drivers to a successful digital transformation
Healthcare industry prioritizes big data and digital and cloud computing for current investments
AI and big data are touted as technologies that can bring disruptive change
Scope
Benchmark the level of business readiness and adoption
Better understand the business functions impacted the most
Assess barriers to adoption
Define requirements for success
Determine the importance of emerging technologies to healthcare organizations
Evaluate levels of investment and to identity current and future investment priorities
Assess the impact of COVID-19, inflation, and other events on digitalization efforts
Explore how artificial intelligence (AI) is disrupting the pharmaceutical sector
Key Topics Covered:
1. Study Design
2. Key Findings
3. Overview of Digital Transformation
4. Digital Transformation Strategy
5. Digital Transformation Objectives
6. Obstacles to Digital Transformation
7. Concerns Associated with Digital Transformation
8. Necessities for Digital Transformation
9. Emerging Technologies – Investment Trends
10. Artificial Intelligence
11. Case Studies
12. Summary of Key Findings
13. Appendix
A selection of companies mentioned in this report includes
Mayo Clinic
Deloitte
Immuneering
InSilico Medicine
Recursion Pharmaceuticals
iSchemaView
Healx
AbSci
Google
OpenAI
Google Cloud Platform
Oncocross
Oma Fertility
Simlo.AI
RIF Robotics
Medicodio
For more information about this report visit https://www.researchandmarkets.com/r/nja996
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo – https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets